Residents Medical Group Creates Pathways For Residency

Undertaking a medical residency is mandatory for all US medical school graduates for them to be able to work as full-time physicians.

The rationale behind this is that, in their role as medical residents working in a real hospital or medical facility environment, the medical school graduates will learn the soft skills and attain the emotional stability and maturity expected of a good, empathetic, and competent physician.

In other words, students acquire knowledge and learn the requisite skills relevant to their specialty during their stay at the medical school. However, working in a real-world and often high-stress medical environment calls for several other skills.

These include the ability to make sound decisions in emergencies; several soft skills such as teamwork, conflict resolution, time management, problem-solving, creative thinking, etc. And it is mainly during one’s medical residency or graduate medical education program that a future physician takes their first steps toward mastering these skills.

Thanks to its affiliation with top US medical schools and health institutions and its collaboration with Residents Medical Group, it has built up a model to find the best residency and fellowship match for every graduate passing through US medical schools.

Alongside Residents Medical Group, The Everest Foundation, a non-profit managed by Dr. Michael Everest and Agata Everest, known for its contribution to raising the standards of graduate medical education and research across the country, aids in helping medical graduates.

The extensive network of Residents Medical Group means that it is best to integrate a candidate into an accredited residency and internship program that perfectly matches the candidate’s skills, credentials, and future goals.

Residents Medical Group has two main ’pathways to placement’ programs to find the right graduate medical education match for all applicants: Clinical to Residency and Research to Residency.

The first is designed to integrate an applicant into an ACGME accredited program through extensive guidance and mentorship by the Residents Medical Group’s residency specialist counselors.

Residents Medical Group has its own evaluation program for all applicants. The evaluation is based on several criteria, including a candidate’s present level of skills, experience, USMLE scores, and more.

Based on this evaluation, candidates are either prepared for direct ’clinical to residency’ programs at top medical institutions in the country. Or, they are advised to undergo Residents Medical Group’s own well-crafted preparatory programs such as ’Extended Medical Externship to Residency’ or ’Unaccredited PGY-1 to Residency.’

According to Residents Medical Group, these programs are designed as the most effective pathways or avenues to find one’s dream residency in the US or globally.

Research to residency programs are meant for students interested in medical research. According to this pathway, deserving applicants are accepted into one of Residents Medical Group’s exclusive paid-research fellowship programs.

These research fellowships are conducted at ACGME accredited teaching hospitals and are available to US and international medical school students and graduates.

These fellowships are integrated into residency training positions, meaning that the researchers can begin their residency at the end of their paid-research tenures.

Contact Information
Mark Richards
Public Relations
Whats New Market Watch
Contact via E-mail

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.


An Advanced Light Helicopter (ALH) from INS Garuda of the Southern Naval Command of the Indian Navy undertook a Medical Evacuation (MEDEVAC) of a female crew of Seychelles Coast Guard Ship (SCGS) Zoroaster on 14 Apr 22. The ship was being escorted by INS Sharda and was on voyage from Kochi to Victoria, Seychelles. At about 0930 hrs on 14 Apr, a crew member of SCGS Zoroaster, reported severe abdominal pains and was shifted to INS Sharda by boat, for further medical management and evacuation.

 Immediately on receipt of information, an indigenously built Advanced Light Helicopter (ALH) and a Seaking 42C helicopter were prepared at Kochi for the medical evacuation. At 1233 hrs, an ALH helicopter with a Naval Medical Officer onboard took off from INS Garuda to effect rendezvous with INS Sharda which was approximately 15 km north of Minicoy Island. The aircraft landed back at Garuda, with the patient at 1650 h. The patient was immediately taken to INHS Sanjivani by ambulance. The patient is under observation and her condition is ‘stable’.



(Release ID: 1816903)
Visitor Counter : 341

Read this release in:


Best Medical Website to be Named by Web Marketing Association in 26th Annual WebAward Competition

 The Web Marketing Association is looking for the best medical websites in the world as part of their 26th annual international WebAward Competition for Web site development at The WebAwards is the standards-defining competition that sets benchmarks for 96 industries, including healthcare, healthcare provider, medical, medical equipment, biotechnology and pharmaceutical websites, based on the seven criteria of a successful web site. The deadline for medical-related websites to enter to be judged is May 31, 2022.

“Excellence deserves recognition. The medical industry is very competitive when it comes to Web development and many companies deserve to be recognized for their online efforts,” said William Rice, President of the Web Marketing Association. “Medical web sites are typically strong in terms of content and copywriting due to their role of helping the organization become a trusted medical source. In past years, judges have also scored these sites well in ease of use, and design; however, they can tend to lag in innovation and use of technology.”

Websites are judged on seven criteria including design, innovation, content, technology, interactivity, copy writing and ease of use. Each WebAward entry in the Health Care category is judged against other healthcare sites and then against an overall standard of excellence.

All medical-related entrants benefit from receiving valuable feedback in terms of their specific criteria scores compared against the average scores for their industry. They also may receive specific comments from the WebAward’s professional judging panel on their Web site development efforts.

Winners of a WebAward in the health care category will also receive:

· Handsome statue or certificate of achievement

· Increased visibility for their company

· Marketing opportunity to promote the company website to the media

· Links to your site from the highly ranked WebAward site to help SEO

· A highlight for your resume.

· Admiration of peers, friends and co-workers

Each year, the Web Marketing Association names the Best of Industry for the various medical categories based on the score they receive from the WebAward judges.

Winners of the Best Medical Web Site include:


· 2020 – LivaNova for LivaNova Website

· 2019 – Global Digital Marketing for HeartLogic Heart Failure Diagnostic Physician Site

· 2018 – Small Army for Boston Medical Center: Pediatric Field Guide Campaign

· 2017 – Scorpion for Ashley County Medical Center

· 2015 – Morrison for QSpex Technologies Website

· 2014 – CommonPlaces, Inc. for Capsule Tech

· 2013 – Bold Array for Summit Imaging Website

· 2012 – Overdrive Interactive for Cold-EEZE Website

· 2011 – Nobel Biocare for Nobel Biocare Dental Professional Website

· 2010 – St. Jude Children’s Research Hospital for Cure4Kids

· 2009 – Fullhouse for GE’s Healthcare’s RSNA 2008 Microsite

· 2008 – Digitas Health for MerckMedicus

· 2007 – Centers for Disease Control an for

· 2006 – WebMD Health for WebMD

· 2005 – Mojo Interactive for

· 2004 – Roche Diagnostics for ACCU-CHEK Web Site

· 2003 – ASCO for

· 2002 – for

Winners of the Best Medial Equipment Web Site include:

· 2021 – Vital for WAVEFORM

· 2020 – Vital for AgaMatrix

· 2020 – Restorative Therapies, Inc. for Restorative Therapies Website Redesign

· 2019 – Global Digital Marketing for HeartLogic Heart Failure Diagnostic Physician Site

· 2018 – Nebo for Contec Clean

· 2017 – FreshForm and Dexcom for Dexcom Healthcare Professional Website

· 2016 – CommonPlaces for BK Ultrasound 2015 – Morrison for QSpex Technologies Website

· 2014 – CommonPlaces, Inc. for Capsule Tech

· 2013 – Bold Array for Summit Imaging Website

· 2012 – pilot for ottobock. Living with Michelangelo.

· 2011 – Pixel Light Digital Media, Inc. for Empi Active product web site

· 2010 – Boston Interactive – Palomar Medical Technologies

· 2009 – Extractable for Thermage Doctors

· 2008 – Great Than One for Guardian REAL – Time Glucose Monitor Tutorial

· 2007 – Cynosure and Small Army for Cynosure Corporate Web Site

· 2006 – for

· 2005 – Roche Diagnostics for MyLabOnline

Winners of the Best Biotechnology Web Site include:


– 2020 – 22 Fillmore for Ikena Oncology Corporate Website

– 2019 – Publicis Sapient and Corteva for Corteva Enterprise Web Experience

– 2018 – Bakir Avdic for Labcyte Inc.

– 2017 – WSI for Myoton

– 2016 – 3 Media Web for MatTek Corporation

– 2015 – Bridgeline Digital for YSI Website

– 2014 – SharpMotion for AceCGT NutriGene Website

– 2013 – Euroweb Internet GmbH for Ulrich Berninger Wassertechnik

– 2012 – Bluetube Interactive for Kimberly Clark Product Selector

– 2011 – Phenomenex, Inc. for

– 2010 – Naturxan CreatiVerge for

– 2009 – Amgen Oncology for Pioneering New Frontiers in Tumor Angiogenesis

– 2008 – Avenue A | Razorfish for

– 2007 – Euro Life x2 for Prolastin

– 2006 – AxxiemCorp for Cara Therapeutics

– 2005 – Risdall Advertising Agency for Hutchinson Technology

– 2004 – Genzyme Corporation/Stellent for Genzyme Web Initiative

– 2003 – Alken-Murray Corporation for Alken-Murray

– 2002 – Hanley-Wood Integrated Marketing for

Winners of the Best Pharmaceutical Web Site include:

– 2021 – AstraZeneca | Patients & Purpose for SURVIVORS HAVE HEART

– 2020 – Eisai Inc. for Ella the Jellyfish

– 2019 – Saltwater Collective for

– 2018 – Aspen Pharmacare Holdings Pty Limited, Bastion Graphics for Aspen Group Website

2017 – JUICE Pharma Worldwide, in partnership with Neurocrine Biosciences for § Precisely Focused on Tardive Dyskinesia

– 2016 – BioMarin for BioMarin Careers

– 2015 – Lyons Consulting Group for

– 2014 – Given Imaging and Intouch Solutions for (Best of Show)

– 2013 – BGT Partners for Quintiles Website Redesign

– 2012 – Intouch Solutions for iBGStar Blood Glucose Monitoring System

– 2011 – Campbell-Ewald for McKesson BOP

– 2010 – Heartbeat Ideas and sanofi-aventis U.S. LLC. for Xyzal Website

– 2009 – Digitas Health for

– 2008 – Publicis Modem for RA Advisor Program

– 2007 – Biggs|Gilmore for Perrigo

– 2006 – Studiocom for CVS Medicare Expert

– 2005 – SimStar for

– 2004 – Abdi Ibrahim Pharma – MagiClick Digital Solutions for Healthcare Portal – Morning After Pill

– 2003 – Insight Interactive Group for Website

– 2002 – ivpcare, inc for ivpcare, inc website

Medial Websites can be entered into consideration for the 2022 Best Medial Website and other medical-related WebAwards at the WebAward Website.

The 2022 WebAwards are sponsored by the following leading organizations:, iContact, and Webmaster Radio. The Web Marketing Association thanks these companies for their commitment to the entire online marketing community.

About the WebAwards

The Web Marketing Association was founded in 1997 to help define the standard of excellence for online marketing. Our internationally known award programs, such as WebAward Competition for Website Development, Internet Advertising Competition and the MobileWebAwards, recognize the people and organizations responsible for developing the most effective online marketing programs on the Internet today. Entrants benefit from assessment of their marketing efforts by a professional judging panel and the marketing opportunities presented by being recognized as an award-winning web developer.


Web Marketing Association

William Rice




  • Awards
  • Biotechnology
  • Communications & Marketing
  • Family Medicine
  • Healthcare Management
  • Medical & Health
  • Medical Products
  • Medical Research
  • Pharmaceuticals
  • Surgery

Aatru Medical Announces Latin America Distribution Agreement for Their Innovative NPSIMS™ Negative Pressure Surgical Incision Management System

 As part of Aatru Medical, LLC (“Aatru”) commercial planning, the company is pleased to announce a Latin America distribution agreement with Salus Biomedical, for the NPSIMS product. The product received recent FDA 510(k) clearance, and Aatru is in the process of finalizing market introduction plans. Initial markets include Latin America, with U.S. and additional global markets to follow.

“We are very excited about this next phase of Aatru development, as we bring the product to market, providing access for clinicians and patients to this truly innovative product,” stated Edward Armstrong, President, Aatru Medical.

The patented NPSIMS utilizes a safe and innovative solid-state chemical reaction to create and apply negative pressure in the therapeutic range to closed incision sites for up to 7 days. The unique mode-of-action, which contains no moving parts or electromechanical components, delivers similar clinical performance to other available Negative Pressure Wound Therapy (NPWT) devices, while providing substantial advantages in patient quality of life, ease of use, and price.

Salus Biomedical is a medical device distributor across Latin America, focusing on hospital use devices. Israel Vierma, Managing Director of Salus Biomedical, stated, “We are proud to be at the forefront of incision care with this simple, most innovative and useful product. Aatru Medical is breaking new ground on ease-of-use for the clinicians and in helping us address a growing need in Latin America.”

Aatru COO Tom Lash noted, “Market analysis and voice-of-customer feedback identified that users value the role of NPWT products in helping manage the risk of surgical site infections (SSI), although product complexity and the high cost of currently-available NPWT products is restricting use to mainly higher-risk incisions only. The NPSIMS product provides similar clinical performance while providing significant cost improvement over existing devices, creating a more scalable standard of care to treat the vast majority of low-exudate surgical incisions.”

About NPWT for closed surgical incisions:

Several post-operative wound complications are common following surgical procedures. Negative pressure wound therapy (NPWT) is well recognized for the management of open wounds, and in the last several years has been applied to closed surgical incisions. Compared with standard postoperative dressings, NPWT has been clinically shown to significantly reduce the rate of surgical site infection and seroma.

About Aatru Medical:

Aatru is a privately held medical device technology company focused on disrupting the surgical incision market with its FDA-cleared NPSIMS, a simple, disposable, single-use, patented, low-cost NPWT device, uniquely designed to require no electromechanical pump, battery or canister.

Introductory videos of the NPSIMS product can be found on the Aatru Medical, LLC website:

Aatru Medical, LLC

Tom Lash




  • Business
  • Medical & Health
  • Medical Products
  • Surgery

FDA Statement on Medical Device User Fee Amendments (MDUFA)


The FDA and representatives from the medical device industry have reached an agreement on proposed recommendations for the fifth reauthorization of the medical device user fee program. Under the new agreement, the FDA would be authorized to collect at least $1.78 billion in user fees over five years, plus additional funding, for a total of up to $1.9 billion to further improve performance if specified goals are met. This funding would provide critical resources to the FDA medical device review program. The proposed recommendations have been posted on our website and will be published in the Federal Register for public comment. Additionally, the MDUFA V public meeting will be held virtually April 19, 2022, to provide the public an opportunity to learn more about and provide their views on the proposed recommendations. The final recommendations are scheduled to be delivered to Congress in April 2022, after FDA considers public input on the proposed recommendations and revises them as necessary.

“The agreement underscores the continued commitment by the FDA and medical device industry to prioritize innovation and increase patient access to safe and effective medical devices,” said Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health. “In addition, MDUFA V represents a substantial investment in the future of the agency’s medical device program and would provide for important improvements, including new hiring targets, greater engagement with developers of innovative technologies based on lessons learned from the pandemic, broadened international harmonization efforts and expanded opportunities to ensure patient perspectives are an integral part of medical device development.” 



The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.